Want to join the conversation?
$FSLR 2Q15 Call: Opex decreased sequentially by $2MM to $107MM. Decrease was driven by lower R&D expenses, partially offset by higher SG&A expenses associated with higher project development spending that was not able to be capitalized against the project. 2Q Opex included an additional $4MM of expenses associated with 8point3 launch.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?